Cargando…
ViBiBa: Virtual BioBanking for the DETECT multicenter trial program - decentralized storage and processing
BACKGROUND: Liquid Biopsy (LB) in the form of e.g., circulating tumor cells (CTCs) is a promising non-invasive approach to support current therapeutic cancer management. However, the proof of clinical utility of CTCs in informing therapeutic decision-making for e.g., breast cancer in clinical trials...
Autores principales: | Asperger, H., Cieslik, J.-P., Alberter, B., Köstler, C., Polzer, B., Müller, V., Pantel, K., Riethdorf, S., Koch, A., Hartkopf, A., Wiesmüller, L., Janni, W., Schochter, F., Franken, A., Niederacher, D., Fehm, T., Neubauer, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176360/ https://www.ncbi.nlm.nih.gov/pubmed/34051621 http://dx.doi.org/10.1016/j.tranon.2021.101132 |
Ejemplares similares
-
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
por: Schochter, Fabienne, et al.
Publicado: (2020) -
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value
por: Franken, André, et al.
Publicado: (2023) -
Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses
por: Heitmeir, Benedikt, et al.
Publicado: (2022) -
The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019) -
Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study
por: Müller, Volkmar, et al.
Publicado: (2012)